Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $19.5 million.

  • Xtant Medical Holdings' Operating Expenses fell 315.18% to $19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year decrease of 855.67%. This contributed to the annual value of $80.3 million for FY2024, which is 2234.67% up from last year.
  • Latest data reveals that Xtant Medical Holdings reported Operating Expenses of $19.5 million as of Q3 2025, which was down 315.18% from $19.7 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Operating Expenses ranged from a high of $21.5 million in Q2 2024 and a low of $8.1 million during Q1 2021
  • Moreover, its 5-year median value for Operating Expenses was $13.8 million (2023), whereas its average is $14.7 million.
  • Per our database at Business Quant, Xtant Medical Holdings' Operating Expenses plummeted by 2623.91% in 2021 and then skyrocketed by 10880.36% in 2023.
  • Xtant Medical Holdings' Operating Expenses (Quarter) stood at $9.6 million in 2021, then rose by 4.41% to $10.0 million in 2022, then soared by 108.8% to $20.9 million in 2023, then fell by 14.5% to $17.9 million in 2024, then grew by 8.63% to $19.5 million in 2025.
  • Its Operating Expenses stands at $19.5 million for Q3 2025, versus $19.7 million for Q2 2025 and $19.2 million for Q1 2025.